Antoine Deslandes | Scientific Advisor – Biotherapeutic Drug Disposition
Sanofi R&D

Antoine Deslandes, Scientific Advisor ? Biotherapeutic Drug Disposition, Sanofi R&D

Antoine Deslandes graduated in Pharmacy and received his Doctorate in Experimental and Clinical Pharmacology from the University of Paris. He joined Servier as preclinical studies manager in Psychiatry/Neurology. He then held different positions in Discovery DMPK at Parke-Davis and joined the eR&D programme at Pfizer Global R&D, as project leader of in-silico tools integration for simulation of biological processes. He then gained experience in Biotechnology as Head of MPK, at the start-up company Gencell, specialized in gene therapy. Since 2006 he works for sanofi-aventis where he initially focused on clinical PK/PD for Oncology Biotherapeutics and is now Scientific Advisor for Biotherapeutics.

Share this

Appearances at this years' conference:

Thursday 24 May 2012- Day Two


@ 17.00
Dose selection for Biologics FIH clinical Trials

- Regulatory background
- Rationale for starting dose determination
- PK/PD endpoints to support dose escalation
- Case studies
 

  • › Antoine Deslandes, Scientific Advisor – Biotherapeutic Drug Disposition, Sanofi R&D
Sponsors
Sponsors
Aptiv Solutions at Exploratory Clinical Development World Europe
Sponsors
CoreLab Partners at Exploratory Clinical Development World Europe
Sponsors
Optimed at Exploratory Clinical Development World Europe
Sponsors
Xceleron at Exploratory Clinical Development World Europe
Sponsors
iCardiac Technologies at Exploratory Clinical Development World Europe
Sponsors
PRA International at Exploratory Clinical Development World Europe